Clostridium, Bacteroides and Prevotella associates with increased fecal metabolites Trans-4-Hydroxy-L-proline and Genistein in active pulmonary tuberculosis patients during anti-tuberculosis chemotherapy with isoniazid-rifampin-pyrazinamide-ethambutol (HRZE)
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
0973-7715
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Clostridium, Bacteroides and Prevotella associates with increased fecal metabolites Trans-4-Hydroxy-L-proline and Genistein in active pulmonary tuberculosis patients during anti-tuberculosis chemotherapy with isoniazid-rifampin-pyrazinamide-ethambutol (HRZE) ; day:24 ; month:3 ; year:2022 ; pages:1-10
Indian journal of microbiology ; (24.3.2022), 1-10
- Urheber
-
Meng, Ruijie
Dong, Wenya
Gao, Jie
Lu, Chunrong
Zhang, Chenchen
Liao, Qinghua
Chen, Liang
Wu, Huizhong
Hu, Jiwen
Wei, Wenjing
Jiang, Zhenyou
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s12088-022-01003-2
- URN
-
urn:nbn:de:101:1-2022061519380954676161
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:30 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Meng, Ruijie
- Dong, Wenya
- Gao, Jie
- Lu, Chunrong
- Zhang, Chenchen
- Liao, Qinghua
- Chen, Liang
- Wu, Huizhong
- Hu, Jiwen
- Wei, Wenjing
- Jiang, Zhenyou
- SpringerLink (Online service)
Ähnliche Objekte (12)
Isoniazid-specific T-cell Responses in patients with anti-tuberculosis drug related liver injury
Treatment of isoniazid-resistant pulmonary tuberculosis
Tuberculosis in Sudan: a study of Mycobacterium tuberculosis strain genotype and susceptibility to anti-tuberculosis drugs
Towards a new tuberculosis drug: pyridomycin – nature's isoniazid
Mycobacterium tuberculosis lineages and anti-tuberculosis drug resistance in reference hospitals across Viet Nam
Adherence to anti-tuberculosis treatment among pulmonary tuberculosis patients: a qualitative and quantitative study
First identification of marine diatoms with anti-tuberculosis activity
Molecular epidemiology study of Mycobacterium tuberculosis and its susceptibility to anti-tuberculosis drugs in Indonesia
Clinical outcomes of multidrug-resistant tracheobronchial tuberculosis receiving anti-tuberculosis regimens containing bedaquiline or delamanid
A metabolic biosignature of early response to anti-tuberculosis treatment
Mycobacterium tuberculosis whole genome sequencing and protein structure modelling provides insights into anti-tuberculosis drug resistance
The Mycobacterium tuberculosisUganda II family and resistance to first-line anti-tuberculosis drugs in Uganda
Isoniazid-specific T-cell Responses in patients with anti-tuberculosis drug related liver injury
Treatment of isoniazid-resistant pulmonary tuberculosis
Tuberculosis in Sudan: a study of Mycobacterium tuberculosis strain genotype and susceptibility to anti-tuberculosis drugs
Towards a new tuberculosis drug: pyridomycin – nature's isoniazid
Mycobacterium tuberculosis lineages and anti-tuberculosis drug resistance in reference hospitals across Viet Nam
Adherence to anti-tuberculosis treatment among pulmonary tuberculosis patients: a qualitative and quantitative study
First identification of marine diatoms with anti-tuberculosis activity
Molecular epidemiology study of Mycobacterium tuberculosis and its susceptibility to anti-tuberculosis drugs in Indonesia
Clinical outcomes of multidrug-resistant tracheobronchial tuberculosis receiving anti-tuberculosis regimens containing bedaquiline or delamanid
A metabolic biosignature of early response to anti-tuberculosis treatment
Mycobacterium tuberculosis whole genome sequencing and protein structure modelling provides insights into anti-tuberculosis drug resistance
The Mycobacterium tuberculosisUganda II family and resistance to first-line anti-tuberculosis drugs in Uganda
Isoniazid-specific T-cell Responses in patients with anti-tuberculosis drug related liver injury
Treatment of isoniazid-resistant pulmonary tuberculosis
Tuberculosis in Sudan: a study of Mycobacterium tuberculosis strain genotype and susceptibility to anti-tuberculosis drugs
Towards a new tuberculosis drug: pyridomycin – nature's isoniazid
Mycobacterium tuberculosis lineages and anti-tuberculosis drug resistance in reference hospitals across Viet Nam
Adherence to anti-tuberculosis treatment among pulmonary tuberculosis patients: a qualitative and quantitative study
First identification of marine diatoms with anti-tuberculosis activity
Molecular epidemiology study of Mycobacterium tuberculosis and its susceptibility to anti-tuberculosis drugs in Indonesia
Clinical outcomes of multidrug-resistant tracheobronchial tuberculosis receiving anti-tuberculosis regimens containing bedaquiline or delamanid
A metabolic biosignature of early response to anti-tuberculosis treatment
Mycobacterium tuberculosis whole genome sequencing and protein structure modelling provides insights into anti-tuberculosis drug resistance